Search details
1.
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03).
Breast Cancer Res Treat
; 169(3): 537-548, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29455298
2.
Type B Lactic Acidosis in a Patient with Mantle Cell Lymphoma.
Case Rep Crit Care
; 2023: 7021123, 2023.
Article
in English
| MEDLINE | ID: mdl-37621746
3.
Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
Oncologist
; 17(1): 13, 2012.
Article
in English
| MEDLINE | ID: mdl-22210086
4.
Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC.
J Thorac Oncol
; 13(10): 1560-1568, 2018 10.
Article
in English
| MEDLINE | ID: mdl-29981927
5.
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.
Cancer Discov
; 8(7): 822-835, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29773717
6.
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
J Thorac Oncol
; 12(6): 932-942, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28315738
7.
ASCO Voices 2020.
J Clin Oncol
; 38(27): 3231-3232, 2020 09 20.
Article
in English
| MEDLINE | ID: mdl-32772763
8.
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.
Cancer Discov
; 5(8): 850-9, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25971938
Results
1 -
8
de 8
1
Next >
>>